NCT03805984: Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers |
|
|
| Completed | 1 | 60 | US | INO-4500, Placebo, SSC-0001, CELLECTRA® 2000 | Inovio Pharmaceuticals, Coalition for Epidemic Preparedness Innovations | Lassa Fever | 10/20 | 10/20 | | |
NCT04093076: Dose-ranging Study: Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers in Ghana |
|
|
| Completed | 1 | 220 | RoW | INO-4500, CELLECTRA™ 2000, Placebo, SSC-0001 | Inovio Pharmaceuticals, Coalition for Epidemic Preparedness Innovations | Lassa Fever | 10/22 | 10/22 | | |
